References
- Valeur J, Øines E, Morken MH, Holst JJ, Berstad A. Plasma glucagon-like peptide 1 and peptide YY levels are not altered in symptomatic fructose-sorbitol malabsorption. Scand J Gastroenterol 2008. In press.
- Cubeddu LX, O'Connor DT, Parmer RJ. Plasma chromogranin A: a marker of serotonin release and of emesis associated with cisplatin chemotherapy. J Clin Oncol 1995; 13: 681–7
- Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 2007; 132: 397–414
- Helle KB, Corti A, Metz-Boutigue MH, Tota B. The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties. Cell Mol Life Sci 2007; 64: 2863–86
- Takiyyuddin MA, Baron AD, Cervenka JH, Barbosa JA, Neumann HP, Parmer RJ, et al. Suppression of chromogranin-A release from neuroendocrine sources in man: pharmacological studies. J Clin Endocrinol Metab 1991; 72: 616–22
- Fykse V, Sandvik AK, Qvigstad G, Falkmer SE, Syversen U, Waldum HL. Treatment of ECL cell carcinoids with octreotide LAR. Scand J Gastroenterol 2004; 39: 621–8
- Salehi A, Qader SS, Grapengiesser E, Hellman B. Pulses of somatostatin release are slightly delayed compared with insulin and antisynchronous to glucagon. Regul Pept 2007; 144: 43–9
- Reisine T. Somatostatin receptors. Am J Physiol 1995; 269: G813–20
- Hauso O, Gustafsson BI, Waldum HL. Long slender cytoplasmic extensions: a common feature of neuroendocrine cells?. J Neuroendocrinol 2007; 19: 739–42
- Cellek S, Thangiah R, Bassil AK, Campbell CA, Gray KM, Stretton JL, et al. Demonstration of functional neuronal beta-3 adrenoceptors within the enteric nervous system. Gastroenterology 2007; 133: 175–83
- Binimelis J, Webb SM, Mones J, Serrano J, Casamitjana R, Elena M, et al. Circulating immunoreactive somatostatin in gastrointestinal diseases. Decrease after vagotomy and enhancement in active ulcerative colitis, irritable bowel syndrome, and duodenal ulcer. Scand J Gastroenterol 1987; 22: 931–7